49288-0403 : Pyrethrum .05 g/ml Intradermal; Subcutaneous Injection, Solution
| NDC: | 49288-0403 |
| Labeler: | Antigen Laboratories, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Pyrethrum |
| Dosage Form: | Intradermal; Subcutaneous Injection, Solution |
| Application #: | BLA102223 |
| Rev. Date: |
NDC Package Codes:
- 49288-0403-1: 2 ML IN 1 VIAL, MULTI‑DOSE (49288‑0403‑1)
- 49288-0403-2: 5 ML IN 1 VIAL, MULTI‑DOSE (49288‑0403‑2)
- 49288-0403-3: 10 ML IN 1 VIAL, MULTI‑DOSE (49288‑0403‑3)
- 49288-0403-4: 30 ML IN 1 VIAL, MULTI‑DOSE (49288‑0403‑4)
- 49288-0403-5: 50 ML IN 1 VIAL, MULTI‑DOSE (49288‑0403‑5)
Active Ingredients:
- Pyrethrum Cinerariifolium
Dosage Strength:
- .05 g/mL
Pharmaceutical Classes:
- Non-Standardized Plant Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Allergens [CS]
- Plant Proteins [CS]
Related Products:
Based on records with the same trade name.- 22840-1533 Pyrethrum .1 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-1535 Pyrethrum .001 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-1559 Pyrethrum 20000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-5516 Pyrethrum .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 54575-273 Pyrethrum 1 g/20ml Percutaneous; Subcutaneous Injection, Solution by Allergy Laboratories, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 49288-0402Next: 49288-0404 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
